Related by context. All words. (Click for frequent words.) 69 MAGE A3 ASCI 69 Tyrima 69 alvimopan 68 Azedra 68 YONDELIS 68 tezampanel 68 Panzem R NCD 68 catheter occlusion 67 LibiGel ® 67 OvaRex ® MAb 67 SNT MC# 67 TELCYTA 67 ZOLINZA 67 riociguat 67 Altropane 67 CoFactor 67 TLK# 67 MYDICAR ® 67 phase IIb clinical 67 oral prodrug 67 Vilazodone 67 herpetic keratitis 67 TOCOSOL Paclitaxel 67 reslizumab 67 elotuzumab 67 MOZOBIL 66 Anturol TM 66 Fibrillex TM 66 selective androgen receptor modulator 66 Bicifadine 66 alvespimycin 66 Tarceva TM 66 opioid induced bowel dysfunction 66 TELINTRA 66 dextofisopam 66 ganetespib 66 TriRima 66 phase IIa clinical 66 Androxal TM 66 sulodexide 66 HGS ETR2 66 tanespimycin 66 oral ridaforolimus 66 refractory Hodgkin lymphoma 66 ISTODAX 66 CCX# 66 AEG# 66 Phase #b/#a clinical 66 forodesine 66 phase IIb trial 66 ONTAK 66 Phase IIIb clinical 66 INCB# [001] 66 LEUKINE 66 AeroLEF TM 66 oxypurinol 66 CINQUIL 66 Cotavance 66 Phenoptin 66 PDX pralatrexate 66 Ventavis 66 torezolid phosphate 66 GAMMAGARD 66 AQ4N 66 OncoVEX GM CSF 66 Phase #b/#a 65 cetuximab Erbitux ® 65 Entereg R 65 PXD# 65 FUSILEV ® 65 PEG SN# 65 Pivotal Phase III 65 OMNARIS HFA 65 CB2 selective receptor agonist 65 adenosine injection 65 dacetuzumab 65 tafamidis 65 TYZEKA 65 PRT# 65 PNP inhibitor 65 PDE4 inhibitor 65 LEP ETU 65 candidate CRLX# 65 Phase III Pivotal 65 IMA# 65 OvaRex R 65 HGS ETR1 65 MGCD# [001] 65 Traficet EN 65 Solazed TM 65 MGd 65 ularitide 65 confirmatory clinical 65 Anturol 65 cediranib 65 TBC# 65 HQK 65 Perforomist ™ Inhalation Solution 65 Xanafide 65 SPARLON 65 Omigard 65 metaglidasen 65 Ophena TM 65 XmAb# 65 mertansine 65 Cloretazine ® 65 ELADUR 65 T Pred 65 RhuDex ® 65 erlotinib Tarceva ® 65 Pimavanserin 65 Ophena 65 refractory gout 65 DAVANAT 65 EOquin 65 HGS# 65 vilazodone 65 Bezielle 65 PREOS R 65 Allovectin 7 R 65 phase III isavuconazole 65 dasatinib Sprycel ® 65 cannabinor 65 Octreolin 65 TREDAPTIVE 65 ApoB SNALP 65 SILENOR 65 diabetic neuropathic pain 64 ICA # 64 Zolinza 64 pralatrexate 64 PANVAC VF 64 rNAPc2 64 ALGRX 64 Degarelix 64 visilizumab 64 calcineurin inhibitors 64 systemic immunosuppressive drugs 64 fund BioSante LibiGel 64 XP# XP# 64 budesonide foam 64 6R BH4 64 severe hypercholesterolemia 64 anidulafungin 64 Generx 64 CINTREDEKIN BESUDOTOX 64 Tasimelteon 64 FOLOTYN ® 64 sorafenib tablets 64 Zenvia ™ 64 EFAPROXYN 64 tezampanel NGX# 64 NGX# 64 Panzem R 64 HCD# [002] 64 Aurexis 64 aplindore 64 Cannabinor 64 atacicept 64 bortezomib Velcade 64 AMEVIVE 64 Locteron ® 64 rALLy 64 Phase IIa trials 64 FOLFOX6 chemotherapy regimen 64 Exherin TM 64 Dalbavancin 64 Zelrix 64 HuLuc# 64 candidate XP# 64 Zemiva TM 64 HuMax CD4 64 vernakalant hydrochloride 64 APTIVUS ritonavir 64 QuadraSphere 64 targeted radiotherapeutic 64 ponatinib 64 bevacizumab Avastin ® 64 Aflibercept 64 R#/MEM # 64 PSMA ADC 64 faropenem medoxomil 64 Targretin 64 Exelixis compounds 64 Azedra TM 64 IL# PE#QQR 64 Azedra ™ 64 Elagolix 64 CORT # 64 PLK1 SNALP 64 Inhalation Solution 64 Gabapentin GR 64 lapatinib Tykerb 64 investigational therapies 64 Plenaxis TM 64 ALVESCO HFA 63 Xcellerated T Cells 63 Troxatyl 63 Phase #b/#a trial 63 Raptiva ® 63 Oracea TM 63 Cleviprex TM clevidipine 63 Phase Ib clinical trials 63 Pazopanib 63 Pyridorin 63 oral methylnaltrexone 63 Triolex 63 octreotide implant 63 Combo Stent 63 Solazed 63 urocortin 2 63 histone deacetylase HDAC inhibitor 63 Locteron 63 TOLAMBA 63 Serdaxin ® 63 CRMD# 63 PROVENGE sipuleucel T 63 AZILECT ® 63 KRN# 63 investigational humanized monoclonal antibody 63 CYT# potent vascular disrupting 63 OMP #R# 63 Diabetic Macular Edema 63 ENMD # 63 Tekamlo 63 clevidipine 63 NeuroSTAT ® 63 mapatumumab 63 Virulizin R 63 Leukine 63 canakinumab 63 Icatibant 63 TACI Ig 63 NATRECOR R 63 novel histone deacetylase 63 novel VDA molecule 63 Rebif ® 63 Telintra 63 Golimumab 63 Phase IIB 63 DDP# 63 lucinactant 63 lomitapide 63 Squalamine 63 IMiDs 63 Gemzar ® 63 severe gastroparesis 63 SPRYCEL ® 63 lintuzumab SGN 63 TRO# 63 enzastaurin 63 acetonide FA 63 Asentar 63 AzaSite Plus 63 RHUCIN 63 dexanabinol 63 recurrent metastatic ovarian cancer 63 OMNARIS Nasal Spray 63 Teflaro 63 Zorbtive TM 63 favorable pharmacokinetic profile 63 Neurodex 63 SILENOR TM 63 HuMax EGFr 63 Neo Urinary Conduit 63 Amplimexon 63 EP #R 63 Phase Ib study 63 tiapamil 63 AZILECT R 63 vidofludimus 63 CBLC# 63 sitaxsentan 63 TORISEL 63 Besivance 63 Dual Opioid 63 Zerenex 63 Celacade TM technology 63 #D#C# 63 R#/MEM 63 docetaxel Taxotere ® 63 thorough QT 63 sunitinib malate 63 MEND CABG 63 Archexin 63 Rhucin ® 63 otelixizumab 63 ALN VSP 63 lesinurad 63 mg/m2 cohort 63 ABILIFY ® 63 radiation sensitizer 63 CCR9 antagonist 63 Protexia ® 63 5 HT3 antagonist 63 evaluating tivozanib 63 zileuton IV 63 MoxDuo IR 63 KNS # 63 INTEGRILIN 63 PS# [001] 63 Amrubicin 63 dirucotide 63 CTAP# Capsules 63 receptor tyrosine kinase inhibitor 63 Clolar ® 63 Excellarate 63 Trofex 63 incyclinide 63 delivers fluocinolone acetonide FA 63 Onalta 63 NeuroStar TMS Therapy 63 pseudobulbar affect PBA 63 Cloretazine R VNP#M 63 INT# [002] 63 thymalfasin 63 Tanespimycin 63 Aerosurf 63 CLIRS trial 63 ramelteon 63 TOCOSOL Camptothecin 63 Iluvien ® 63 interferon gamma 1b 63 SARMs 63 OXi# 63 ELND# 63 RSD# oral 63 neratinib 63 Hedgehog Pathway Inhibitor 63 ALN PCS 63 elagolix 63 BLA filing 63 TRANSDUR ® 63 STRIDE PD 63 refractory chronic lymphocytic 63 Lu AA# 63 GALNS 63 treat dysmenorrhea 63 topically applied SEPA 62 Arikace 62 confirmatory Phase III 62 phase IIb study 62 candidate Zenvia 62 registrational 62 lenalidomide Revlimid R 62 Gel repository corticotropin injection 62 pharmacodynamic properties 62 MEK inhibitor RDEA# 62 refractory angina 62 Zelapar 62 Kamada AAT 62 PREOS 62 tamibarotene 62 regadenoson 62 ostarine 62 GLASSIA 62 Dasatinib 62 molecular imaging radiopharmaceutical 62 ELACYT 62 eltrombopag 62 Navelbine ® 62 anticancer compound 62 LymphoStat B 62 liposomal formulation 62 drug ISA# 62 Zingo TM 62 posaconazole 62 subcutaneous formulation 62 renal toxicity 62 BRIM2 62 Adcirca 62 Tamibarotene 62 Annamycin 62 Silodosin 62 generation purine nucleoside 62 GEM OS2 62 Egrifta 62 IRX 2 62 Cellegesic 62 NUVIGIL 62 oxymorphone ER 62 ranolazine 62 ONCONASE 62 CA4P 62 liposomal doxorubicin 62 Orazol 62 Kepivance 62 LE SN# 62 CR# vcMMAE 62 relapsed refractory multiple myeloma 62 non alcoholic steatohepatitis 62 DXL# 62 Chemophase 62 ezogabine 62 Cloretazine 62 JAK inhibitor 62 CIMZIA ™ 62 MEK Inhibitor 62 Diovan HCT 62 Vicinium TM 62 gabapentin enacarbil 62 bicifadine 62 SinuNase TM 62 R lenalidomide 62 phase Ib 62 ARCOXIA 62 ATACAND 62 MAXY G# 62 Cintredekin Besudotox 62 Zenvia Phase III 62 TG# [003] 62 Cardio Vascu Grow 62 assessing T DM1 62 daclizumab 62 Targretin capsules 62 Arcalyst 62 Nuvion 62 Adentri 62 Thalomid ® 62 Aviptadil 62 sargramostim 62 postoperative ileus POI 62 SNRI 62 aldehyde dehydrogenase ALDH2 deficiency 62 sorafenib Nexavar 62 vandetanib 62 Aganocide 62 brivaracetam 62 Personalized Immunotherapy 62 Eli Lilly Cymbalta 62 phase IIa 62 galiximab 62 severe hypersensitivity reactions 62 Phase 2a trial 62 AGILECT R 62 midstage trials 62 zileuton CR 62 desvenlafaxine 62 EndoTAG TM -1 62 GED aPC 62 investigational antiplatelet agent 62 phase IIb 62 Stimuvax R 62 OMS#HP 62 SEPET TM 62 AZOR 62 sodium Injection 62 Zemiva ™ 62 ongoing Phase IIIb 62 velafermin belinostat 62 ocular formulation 62 RLY# 62 EOquin TM 62 adipiplon 62 vosaroxin 62 cinacalcet HCl 62 VISICOL R 62 sapropterin dihydrochloride Tablets 62 BiovaxID TM 62 IV APAP 62 trastuzumab DM1 T DM1 62 methylnaltrexone bromide 62 IAP inhibitor 62 European Sepsis Trial 62 FACTIVE tablets 62 velafermin 62 intravenous acetaminophen 62 Clonicel 62 Ketotransdel 62 talactoferrin 62 RGB # 62 GLP toxicology studies 62 Phase III Clinical Trial 62 dasatinib Sprycel 62 Phase 2a clinical trials 62 uric acid lowering 62 pertuzumab 62 XL# XL# XL# 62 Lymphoseek ® 62 rALLy trial 62 Sym# 62 Panzem 62 ZEGERID Capsules 62 axitinib 62 Ketotransdel TM 62 Neo Kidney Augment ™ 62 Myocet 62 2 methoxyestradiol 62 EchoCRT 62 Genasense R oblimersen 62 placebo controlled clinical 62 Tezampanel 62 PolyActive ® 62 ruxolitinib 62 Symadex 62 generation Hsp# inhibitor 62 Tesetaxel 62 Fx #A 62 either acutely decompensated 62 AGGRASTAT ® 62 GTC recombinant human 62 XL# anticancer compounds 62 oral dual endothelin 61 VNP#M 61 Q#IR 61 fosbretabulin 61 cystinosis patients 61 ZEVALIN ® 61 Sapacitabine 61 CEQ# 61 Topical Interferon Alpha 2b 61 lumiliximab 61 REG1 61 cangrelor 61 hoFH 61 Generx TM 61 Proquin XR 61 PEP# [003] 61 orally administered inhibitor 61 PRTX 61 mecarbil 61 Evoltra ® 61 R sorafenib tablets 61 GSK# [001] 61 ZYBRESTAT 61 LibiGel Phase III 61 INTEGRILIN ® 61 R roscovitine 61 endothelin receptor antagonists 61 darapladib 61 ZADAXIN ® 61 huC# DM4 61 mGluR5 NAM 61 Pivotal Trial 61 rhThrombin 61 Acetavance 61 custirsen 61 Excellarate TM 61 Cinryze ™ 61 Valdoxan 61 Androxal 61 Hyphanox 61 belinostat 61 Menerba 61 teriflunomide 61 omacetaxine mepesuccinate 61 GSK# [002] 61 RSD# 61 BAY #-# 61 AzaSite Xtra 61 Dupuytren Disease 61 virus HCV protease inhibitor 61 Xcytrin R 61 MERLIN TIMI 61 DR Cysteamine 61 investigational monoclonal antibody 61 Entereg TM 61 Combidex 61 Torisel 61 NVA# 61 ALTROPANE 61 Viprinex 61 lintuzumab 61 Firazyr 61 Cetrorelix 61 Urocortin 2 61 Pafuramidine 61 LY# [003] 61 maribavir 61 Dextofisopam 61 gefitinib Iressa 61 samalizumab 61 Chrysalin 61 antiarrhythmic drug 61 MAA submission 61 HuMax CD# 61 cilengitide 61 immunomodulatory therapy 61 IMC #B 61 Pivotal Phase 61 Dyloject TM 61 obatoclax 61 NEUGENE 61 including eniluracil ADH 61 Phase 2b study 61 multicenter Phase III 61 phase IIb III 61 Abbokinase 61 AAG geldanamycin analog 61 atrial fibrillation budiodarone ATI 61 EVIZON TM 61 BEMA Buprenorphine 61 successfully commercialize Iluvien 61 Soliris eculizumab 61 phase Ib clinical 61 hormone LHRH antagonist 61 CAPHOSOL 61 LHRH antagonists 61 BCX# 61 oral nucleoside analogue 61 refractory APL 61 prGCD 61 NP2 Enkephalin 61 MIST II 61 PROMACTA 61 Plicera 61 Fortical R 61 aripiprazole Abilify 61 EVIZON TM squalamine lactate 61 CANCIDAS 61 antiangiogenic agents 61 Pemetrexed 61 hereditary deficiency 61 pharmacokinetic PK 61 TRV# [001] 61 DACH platinum 61 Mipomersen 61 Serada 61 Onconase 61 ORENCIA R 61 Onalta ™ 61 Frova ® 61 bevacizumab Avastin 61 AGGRASTAT R 61 Allovectin 7 61 IMC A# 61 acyclovir Lauriad R 61 dosing cohort 61 tramiprosate Alzhemed TM 61 registrational trials 61 FROVA 61 DIFICID 61 MGN# 61 ixabepilone 61 TAXUS TM 61 sodium thiosulfate STS 61 Phase Ib 61 tolevamer 61 Phase 2b Clinical Trial 61 MyVax R 61 Prodarsan ® 61 Phase Ib clinical 61 ATryn ® 61 ORENCIA ® 61 teduglutide 61 Nexavar ® 61 Sular formulation 61 Intravenous CP 61 Solazed ™ 61 MYCAMINE 61 CCR5 antagonist 61 ATryn R 61 dimebon 61 albiglutide 61 MDV# 61 CHAMPION PCI 61 liprotamase 61 vascular disrupting agents 61 AVASTIN 61 ITAX 61 dextromethorphan quinidine 61 candidate deforolimus 61 bafetinib 61 vernakalant oral 61 APTIVUS r 61 Prodarsan 61 nalbuphine ER 61 Dapagliflozin 61 TRISENOX ® 61 SERMs 61 Dacogen injection 61 ATPace TM 61 Meets Primary Endpoint 61 Shigamabs ® 61 NATRECOR ® 61 Synavive 61 Azixa 61 KETEK 61 registrational trial 61 tivozanib 61 omega interferon 61 faropenem 61 candidate epratuzumab 61 OMAPRO 61 Prostate AdenoCarcinoma Treatment 61 PREZISTA r 61 metastatic sarcomas 61 APEX PD 61 VIVITROL ® 61 rilonacept 61 hypoxia activated prodrug 61 Onco TCS 61 PSN# [002] 61 ONCONASE R 61 proteasome inhibitor 61 ELADUR ™ 61 serum phosphorous 61 oral picoplatin 61 TKM ApoB 61 PrevOnco ™ 61 LEVAQUIN ® 61 ALN HPN 61 aflibercept VEGF Trap 61 MYDICAR 61 NOX E# 61 regorafenib 61 R Saizen R 61 Ceflatonin 61 evaluating Actimmune 61 SCH # 61 THR beta agonist 61 Northera 61 valopicitabine 61 ProSavin 61 arsenic trioxide injection 61 INCB# [002] 61 tecarfarin 61 ENDEAVOR IV 61 NXL# 61 COREG CR 61 RhuDex 61 adecatumumab 61 Cimzia R 61 thrombolytic agent 61 ospemifene 61 diarrhea predominant irritable 61 Phase Ib II 61 XL# XL# XL# XL# 61 Somatuline R Depot 61 interferon beta 1b 61 refractory PTCL 61 ADL# novel 61 Dose escalation 61 eniluracil 61 anti amnesic 61 LHRH antagonist 61 PRX # 61 Veronate 61 Perifosine 61 FIRMAGON R 61 Romidepsin 60 sapacitabine 60 HCV protease inhibitor 60 relapsed multiple myeloma 60 TLR8 agonist 60 MT#/MEDI-# 60 CIMZIA TM 60 Glufosfamide 60 RG# [001] 60 modified glutathione analog 60 overactive bladder AA# 60 ONGLYZA ™ 60 TRIOLEX HE# APOPTONE HE# 60 PrevOnco 60 TRANSDUR ™ 60 fenofibric acid 60 Known hypersensitivity 60 TRANSDUR Sufentanil 60 5 lipoxygenase inhibitor 60 initiate Phase 1b 60 memantine HCl 60 Aclidinium 60 candidate TNFerade biologic 60 Trofex TM 60 Proxinium TM 60 metformin accumulation 60 opioid bowel dysfunction 60 Varespladib 60 Capesaris 60 leading oral taxane 60 PROVENGE ® 60 antibody MAb 60 Bortezomib 60 Vandetanib 60 RAPTIVA 60 nab paclitaxel 60 Resten NG 60 platelet inhibitor 60 indibulin 60 NEUMUNE 60 BrachySil 60 Vernakalant 60 PROVIGIL 60 confirmatory Phase 3 60 candidate AQ4N 60 PEGINTRON TM 60 muraglitazar 60 dose escalation phase 60 SPRIX ® 60 brand ciclesonide HFA 60 SUPPRELIN R LA 60 Sanctura XR 60 LUMINATE 60 Desmoteplase 60 Lixivaptan 60 OPAXIO 60 ACAPODENE 60 TREANDA 60 Alzhemed TM 60 JAK2 inhibitor 60 HepeX B TM 60 PEGylated anti 60 inhaled formulation 60 Shigamabs R 60 SAR# [004] 60 Alfimeprase 60 Rasilez Tekturna 60 Marqibo 60 ADVANCE PD 60 BRIM3 60 Panitumumab 60 Celacade TM 60 balsalazide tablet 60 bardoxolone methyl 60 epigenetic therapies 60 IND submission 60 milnacipran 60 UltiMAb ® 60 Oral NKTR 60 transthyretin mediated amyloidosis ATTR 60 vapreotide acetate 60 AQUAVAN R 60 TNF Tumor Necrosis Factor 60 blinded randomized placebo controlled 60 FRDA 60 Fibrin Pad 60 paclitaxel Taxol ® 60 OHR/AVR# 60 Cloretazine R 60 Initiates Enrollment 60 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 60 Iloperidone 60 cMET 60 Carvedilol 60 ARIKACE ™ 60 refractory multiple myeloma 60 IMGN# 60 Serdolect ® 60 Ixempra 60 hyperphenylalaninemia HPA due 60 APTIVUS 60 Corlux 60 PFO migraine 60 Neuradiab 60 HepeX B 60 ALTROPANE R 60 oral gallium 60 oral rivaroxaban 60 AEGR 60 pradefovir 60 BENICAR HCT 60 BEMA Granisetron 60 chemotherapy induced neutropenia 60 topical NSAID 60 BEXXAR 60 THALOMID 60 OPT CHF 60 Nasulin 60 Inhalation Aerosol 60 carcinoid syndrome 60 UPLYSO 60 INTEGRILIN R 60 ACTEMRA TM 60 PEG PAL 60 Xinlay 60 individualized cellular immunotherapy 60 dihydrochloride Tablets 60 Leukine ® 60 Allovectin 7 r 60 Genasense ® oblimersen 60 rALLy clinical trial 60 relapsed MM 60 Phase 2a Clinical Trial 60 BLA submission 60 Aloxi injection 60 squalamine 60 bazedoxifene 60 dalbavancin 60 FACTIVE R gemifloxacin 60 TPI ASM8 60 terlipressin 60 nonclinical studies 60 Lubiprostone 60 Serostim ® 60 Quinamed 60 alpha interferons 60 candidates Augment ™ 60 pegylated interferons 60 Triapine R 60 ATL# [002] 60 recurrent herpes labialis 60 ALVESCO ® 60 esophageal candidiasis 60 Nanobody 60 intravesical infusion therapy 60 Velcade bortezomib 60 PEGylated interferon beta 1a 60 Zemplar Capsules 60 JAK1 60 FM VP4 60 selective A2A adenosine receptor 60 PROSTASCINT R 60 Zytiga 60 docetaxel Taxotere R 60 Technosphere Insulin 60 pomalidomide 60 double blinded placebo 60 celgosivir 60 efficacy tolerability 60 RECOTHROM R 60 pimozide 60 TNF alpha inhibitor 60 Rescula 60 Zoraxel 60 xanthine oxidase inhibitor 60 COSIRA trial 60 LUVENIQ 60 SinuNase 60 BEMA TM Fentanyl 60 investigational pharmacologically unique 60 gastrointestinal stromal tumors GIST 60 CYCLOSET 60 phase III ACCLAIM 60 #I TM# 60 atherothrombotic events 60 refractory metastatic colorectal cancer 60 bardoxolone 60 IV Busulfex 60 Allovectin 7 ® 60 insulin sensitizing 60 Phase IIIb 60 GATTEX ® 60 schizophrenia CIAS 60 Alexza Staccato 60 PREGNANT Study 60 Augment TM 60 BETAS 60 delivery polymer matrix 60 Actimmune ® 60 novel oral anticoagulant 60 vitreoretinal disorders 60 GW# [003] 60 oral calcitonin 60 CLARITY study 60 bosutinib 60 Dupuytren Contracture 60 cutaneous T cell 60 solanezumab 60 BZL# 60 pegloticase 60 PHX# 60 oral talactoferrin 60 ENRICH trial 60 thalidomide Thalomid 60 OSMOPREP 60 Anturol ® 60 candidate NGX 60 standard chemotherapy regimen 60 ZYBRESTAT fosbretabulin 60 CD# monoclonal antibody 60 evaluating Xcytrin 60 icatibant 60 CDP# 60 pan HDAC inhibitor 60 Phase 1a clinical 60 MAXY VII 60 Vidofludimus 60 ATL# [001] 60 Prednisporin 60 Advagraf 60 ancrod 60 AVONEX ® 60 Anidulafungin 60 MYLOTARG 60 IAP inhibitors 60 DUROS 60 DURECT proprietary 60 M6G 60 Phase IIb trials 60 elective PCI 60 PRECISE trial 60 olaparib 60 zileuton 60 Lauriad 60 Ocrelizumab 60 Tekturna HCT 60 eosinophilic asthma 60 GP IIb IIIa inhibitors 60 myopathy rhabdomyolysis 60 metastatic HRPC 60 MKC# MKC# PP 60 ketolide antibiotic 60 UVIDEM 60 VITAL Trial 60 superficial bladder cancer 60 tramiprosate 60 Rilonacept 60 recurrent glioblastoma multiforme 59 ILUVIEN ®